Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • mitsaki
    Junior Member
    • Nov 2013
    • 2

    10x genomics

    Hi everyone,

    I am kind of new to rna seq and mostly to 10x genomics. I got some data from a 10x genomics and in contrast to Hiseq/Nextseq etc, I have 4 types of files.

    I have R1,R2,R3 and I1 files. I am a bit confused about what is what. So R1 has reads of 114 length so it should be my sequence. The R2 files have sequences of 14bp (is that the 10x barcode ?)
    R3 contain sequences of 10 bp (UMI ?) and I1 should be sample barcodes

    Could someone help me clear this out ?
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    You would find it pretty hard to work with these files in a standalone manner (I am not sure why you have an R3 file). I assume this is single cell RNAseq data? You should ask your sequence provider to process this data with 10x Cellranger software (unless you are willing and capable of installing/running this software yourself). You can find information about CellRanger here.

    Comment

    • mitsaki
      Junior Member
      • Nov 2013
      • 2

      #3
      Thank you for your reply. Yes it is RNAseq data. The R3 file is the one that mostly confuses me too. We are the sequence provider and we have cell ranger. But we want to run some tests for a specific experiment standalone

      So, I thought that I could treat R1 as single end and run star. It seems to work but the rest of the files made me confused, because I do not actually use them

      Comment

      • GenoMax
        Senior Member
        • Feb 2008
        • 7142

        #4
        How was this run set up (on sequencer)? It looks like the UMI's were treated like a separate read and must have ended up in one of the files.

        I assume you used the mkfastq protocol to generate the files? What was the --use-bases-mask used? And the <RunInfo> section from RunInfo.xml?
        Last edited by GenoMax; 06-15-2017, 12:30 PM.

        Comment

        • nucacidhunter
          Jafar Jabbari
          • Jan 2013
          • 1250

          #5
          Your explanation of files is correct and the data set must be for v1 chemistry which is obsolute. If you are planning runs and want to evaluate the performance or check your software set up you should download data for v2 chemistry which has different library structure and sequencing configuration.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          25 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-23-2026, 11:41 AM
          0 responses
          20 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-20-2026, 11:10 AM
          0 responses
          28 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-13-2026, 10:26 AM
          0 responses
          38 views
          0 reactions
          Last Post SEQadmin2  
          Working...